Where Found: Ubiquitous in soil and air; contaminates cannabis through spores during drying or poor storage.
Health Effects: Pulmonary aspergillosis, invasive infections, and sepsis.
At-Risk Populations: Transplant patients, leukemia patients, and others with suppressed immunity.
Where Found: Soil and humid environments post-harvest
Health Effects: Produces ochratoxin A—linked to kidney and liver damage; respiratory infections possible.
At-Risk Populations: Individuals with chronic lung disease or immunocompromise.
Where Found: Grows in cultivation media like peat moss and coco coir.
Health Effects: Produces fumonisins and trichothecenes; may cause hepatotoxicity and neurotoxicity.
At-Risk Populations: Cancer patients; pregnant individuals.
Where Found: Thrives in humid cultivation environments.
Health Effects: Causes allergic sensitization and, occasionally, lung infections.
At-Risk Populations: Individuals with asthma or chronic respiratory conditions.
Where Found: Soil enriched with bird droppings and improperly stored cannabis.
Health Effects: Causes cryptococcal meningitis and pulmonary infections.
At-Risk Populations: HIV/AIDS patients; transplant recipients; potentially immunocompetent (healthy) individuals.
Clinical Case: A woman with no evidence of immunodeficiency developed C. neof
Where Found: Soil enriched with bird droppings and improperly stored cannabis.
Health Effects: Causes cryptococcal meningitis and pulmonary infections.
At-Risk Populations: HIV/AIDS patients; transplant recipients; potentially immunocompetent (healthy) individuals.
Where Found: Found in decaying plant matter and humid post-harvest storage.
Health Effects: Causes mucormycosis, a rapidly fatal invasive infections involving lungs or brain.
At-Risk Populations: Individuals with HIV/AIDS, diabetes, and transplant recipients.
Where Found: Soil; thrives in anaerobic post-harvest conditions.
Health Effects: Botulism; neurotoxin-induced paralysis.
At-Risk Populations: Immunosuppressed patients.
Where Found: Contaminated irrigation water, soil, and unclean post-harvest handling.
Health Effects: Gastroenteritis, dehydration, sepsis.
At-Risk Populations: Infants, elderly, immunocompromised individuals.
Where Found: Water and handling equipment.
Health Effects: Respiratory and bloodstream infections.
At-Risk Populations: Hospitalized patients and immunocompromised individuals.
Where Found: Soil and water; often introduced post-harvest.
Health Effects: Severe pneumonia, liver abscesses, sepsis.
At-Risk Populations: Diabetic, elderly, or immunocompromised patients.
Where Found: Irrigation systems, soil, and humid storage areas.
Health Effects: Causes UTIs, sepsis, and pneumonia; resistant strains common.
At-Risk Populations: Burn victims, CF patients, and hospitalized individuals.
Even on the healthiest of plants, a diverse community of microorganisms exists. These include:
Epiphytes: Fungi and bacteria living on the surface of the flowers and leaves. Spores of molds like Penicillium and Aspergillus might already be present.
Endophytes: Microbes residing inside the plant tissues. Some can be latent pathogens, waiting for the right conditions.
Freshly harvested buds are full of moisture, a literal playground for microbes. If buds are not dried quickly and efficiently to the proper water content, the environment is ripe for microbial proliferation.
High water activity: microbes, especially molds, thrive when water activity is high, generally above .7 Aw. Slow drying keeps the Aw in the danger zone for too long.
Stagnant Air and Humidity: Poor airflow during drying exacerbates the problems, trapping moisture and creating humid microclimates within piles of drying plant material
Mycotoxin Production: Some of these molds are not just unsightly; they produce mycotoxins, toxic chemical compounds that can be harmful to human health. Even if the mold itself dies or is removed, these toxins can linger. Examples include aflatoxins(from Aspergillus), ochratoxins (from Aspergillus and Penicillium), and fumonisins (from Fusarium).
The consequences of these microbial contaminants can be significant:
The good news is that these risks are largely preventable with proper post-harvest techniques.
Produced By: Aspergillus flavus and Aspergillus parasiticus
Health Risks:
Why It Matters for C
Produced By: Aspergillus flavus and Aspergillus parasiticus
Health Risks:
Why It Matters for Cannabis Consumers:
Produced By: Aspergillus and Penicillium species
Health Risks:
Produced By: Aspergillus and Penicillium species
Health Risks:
Why It Matters for Cannabis Consumers:
Produced By: Fusarium species
Health Risks:
Why It Matters
Produced By: Fusarium species
Health Risks:
Why It Matters for Cannabis Consumers:
Testing of California dispensary samples revealed yeast and mold counts exceeding 10,000 CFU/g, highlighting serious microbial contamination in products marketed to medical patients.
The CDC published an analysis showing cannabis users were 3.5× more likely than non-users to develop fungal infections, even after adjusting for age and immunocompromised status.
1. McHardy, I., Romanelli, A., Harris, L. J., Opp, G., Gaudino, R., Torres, A., Polage, C. R., Tuscano, J. M., & Thompson, G. R., 3rd (2018). Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients?. The Journal of infection, 76(5), 500–501. https://doi.org/10.1016/j.jinf.2018.01.010
2. Shapiro, B. B., MD, MPH, Hedrick, R., Vanle, B. C., Becker, C. A., Nguyen, C., Underhill, D. M., Morgan, M. A., Kopple, J. D., Danovitch, I., & IsHak, W. W. (2018). Cryptococcal meningitis in a daily cannabis smoker without evidence of immunodeficiency. BMJ case reports, 2018, bcr2017221435. https://doi.org/10.1136/bcr-2017-221435
3. Stone, T., Henkle, J., & Prakash, V. (2019). Pulmonary mucormycosis associated with medical marijuana use. Respiratory medicine case reports, 26, 176–179. https://doi.org/10.1016/j.rmcr.2019.01.008
4. Benedict, K., Thompson, G. R., & Jackson, B. R. (2020). Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016. Emerging Infectious Diseases, 26(6), 1308-1310. https://pmc.ncbi.nlm.nih.gov/articles/PMC7258471/
5. Gwinn, K. D., Leung, M. C. K., Stephens, A. B., & Punja, Z. K. (2023). Fungal and mycotoxin contaminants in cannabis and hemp flowers: implications for consumer health and directions for further research. Frontiers in microbiology, 14, 1278189. https://doi.org/10.3389/fmicb.2023.1278189
6. Boyar, K. (2022). Cannabis Microbial Testing: Methodologies and Considerations. In Recent Advances in the Science of Cannabis (1st ed., Vol. 1, pp. 131–160). CRC Press. https://doi.org/10.1201/9780429274893-6
7. Sarma, N. D., Waye, A., ElSohly, M. A., Brown, P. N., Elzinga, S., Johnson, H. E., ... & Giancaspro, G. I. (2020). Cannabis inflorescence for medical purposes: USP considerations for quality attributes. Journal of Natural Products, 83(4), 1334–1351. https://doi.org/10.1021/acs.jnatprod.9b01200
8. Foundation of United Cannabis Standards . (2016, May 25). APHL guidance for state medical cannabis testing programs. FOCUS. https://www.focusstandards.org/aphl-guidance-state-medical-cannabis-testing-programs/
9. Verweij, P. E., Kerremans, J. J., Voss, A., & Meis, J. F. (2000). Fungal contamination of tobacco and marijuana. JAMA : The Journal of the American Medical Association, 284(22), 2875-. https://doi.org/10.1001/jama.284.22.2869
10. Sullivan, N., Elzinga, S., Raber, J. C., & Bursian, S. J. (2013). Determination of Pesticide Residues in Cannabis Smoke. Journal of Toxicology, 2013(2013), 1–6. https://doi.org/10.1155/2013/378168
11.Craven, C. B., Wawryk, N., Jiang, P., & Li, X.-F. (2019). Pesticides and trace elements in cannabis: Analytical and environmental challenges and opportunities. Journal of Environmental Sciences, 85, 82–93. https://doi.org/10.1016/j.jes.2019.04.028
12. Toth, J., & Rawson, J. (2024, January 19). Pesticides in cannabis - an explainer. Institute of Cannabis Science. https://cannsci.org/f/pesticides-in-cannabis---an-explainer?page_id=285&blogcategory=Pesticides
13. Pinkhasova, D. V., Jameson, L. E., Conrow, K. D., Simeone, M. P., Davis, A. P., Wiegers, T. C., Mattingly, C. J., & Leung, M. C. K. (2021). Regulatory status of pesticide residues in cannabis: Implications to medical use in neurological diseases. Current Research in Toxicology, 2, 140–148. https://doi.org/10.1016/j.crtox.2021.02.007
14. Pruyn, S. A., Wang, Q., Wu, C. G., & Taylor, C. L. (2022). Quality Standards in State Programs Permitting Cannabis for Medical Uses. Cannabis and Cannabinoid Research, 7(6), 728–735. https://doi.org/10.1089/can.2021.0164
15. Seltenrich, N. (2019). Cannabis Contaminants: Regulating Solvents, Microbes, and Metals in Legal Weed. Environmental Health Perspectives, 127(8), 82001-. https://doi.org/10.1289/EHP5785
16. St. John, P., Greene, S., & Elebee, L. I. (2024, December 19). Search your stash: 538 cannabis pesticide tests show what’s In your weed. Los Angeles Times. https://www.latimes.com/california/story/2024-12-19/we-tested-cannabis-products-for-pesticides-how-dirty-is-your-weed
17. Casacchia, C. (2025, February 6). CA issued 63 cannabis recalls, 500 product embargoes in 2024. MJBizDaily. https://mjbizdaily.com/california-issued-63-cannabis-recalls-nearly-500-product-embargoes-in-2024/#:~:text=Recalls%20up%20amid%20pesticide%20outbreak,and%20nearly%2025%2C000%20individual%20units.
18. Jameson, L. E., Conrow, K. D., Pinkhasova, D. V., Boulanger, H. L., Ha, H., Jourabchian, N., Johnson, S. A., Simeone, M. P., Afia, I. A., Cahill, T. M., Orser, C. S., & Leung, M. C. K. (2022). Comparison of State-Level Regulations for Cannabis Contaminants and Implications for Public Health. Environmental health perspectives, 130(9), 97001. https://doi.org/10.1289/EHP11206
19. Robertson, S. (2025, March 6). Burning questions plague cannabis testing industry. The Shoestring. https://theshoestring.org/2025/03/06/burning-questions-plague-cannabis-testing-industry/
20. St. John, P. (2024, December 19). Cannabis conundrum: Legal doesn’t mean clean; illicit isn’t always dirty. Los Angeles Times. https://www.latimes.com/california/story/2024-12-19/legal-and-illegal-cannabis-products-pose-hidden-health-risks
21. Procter, S., Baird, G.L. & Iannuccilli, J. Peer-review Blinded Assay Test (P-BAT): a framework for trustless laboratory quality assurance for state-regulated cannabis markets. J Cannabis Res 7, 4 (2025). https://doi.org/10.1186/s42238-025-00261-3
22. Racino, B. (2023, September 20). NY’s testing failures expose legal weed consumers to unsafe cannabis; a “serious health threat.” Syracuse. https://www.syracuse.com/marijuana/2023/09/nys-testing-failures-expose-legal-weed-consumers-to-unsafe-cannabis-a-serious-health-threat.html
23. Business Wire / Royal Queen Seeds. (2025). New survey shows many Americans concerned about unsafe cannabis. https://www.businesswire.com/news/home/20250410575085/en/New-Survey-Shows-Many-Americans-Concerned-About-Unsafe-Cannabis
24. Diggama Consulting. (2024, March 13). White Paper: Soultions to Cannabinoid Inflation. Drug Enforcement Administration. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwig7crJxaSNAxUuJEQIHTOaMVUQFnoECB0QAQ&url=https%3A%2F%2Fdownloads.regulations.gov%2FDEA-2024-0059-35496%2Fattachment_1.pdf&usg=AOvVaw1q2j2VEIkDll5LktMJXpnm&opi=89978449
25. Szyper-Kravitz, M., Lang, R., Manor, Y., & Lahav, M. (2001). Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking. Leukemia & lymphoma, 42(6), 1433–1437. https://doi.org/10.3109/10428190109097776
Cannabis Cate
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.